Ball Titus B. sold $632K of ONC
Ball Titus B. (Principal Accounting Officer) sold 1,559 shares of BeOne Medicines Ltd. (ONC) at an average of $405.57 ($405.55–$406.34, $0.63M total) across 2 trades on 2026-11-06.
How this was made
The 30-second read
Why it matters
The sale may be interpreted as a negative signal, but the modest size limits market reaction.
Market read
A routine insider sale with modest dollar value; likely limited impact on price.
What to watch
No 10b5‑1 plan; the officer may be diversifying personal holdings.
Background
Form 4 filings provide primary disclosure of insider transactions. This filing reports a complete exit by a senior officer.
Ticker impact
Principal Accounting Officer sold 1,559 shares for $632K, reducing holdings to zero.
likely downward pressure as market prices in the insider sell
A C-level officer exiting completely can be viewed as a negative signal, though the amount is modest for a mid‑cap biotech.
Market effects
May prompt scrutiny of other biotech insider activity but limited sector impact.
Minimal effect on broader US market.
Low
Counterpoint
The sale could be a routine liquidity move unrelated to company outlook.
Key entities
- CompanyBeOne Medicines Ltd.
Biotech firm listed on Nasdaq under ticker ONC.
- IndividualBall Titus B.
Principal Accounting Officer of BeOne Medicines.
